233 related articles for article (PubMed ID: 27585490)
1. Whole-body diffusion-weighted magnetic resonance imaging in the diagnosis of recurrent ovarian cancer: a clinical feasibility study.
Michielsen KL; Vergote I; Dresen R; Op de Beeck K; Vanslembrouck R; Amant F; Leunen K; Moerman P; Fieuws S; De Keyzer F; Vandecaveye V
Br J Radiol; 2016 Nov; 89(1067):20160468. PubMed ID: 27585490
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of whole body diffusion-weighted MRI compared to computed tomography for pre-operative assessment of patients suspected for ovarian cancer.
Michielsen K; Dresen R; Vanslembrouck R; De Keyzer F; Amant F; Mussen E; Leunen K; Berteloot P; Moerman P; Vergote I; Vandecaveye V
Eur J Cancer; 2017 Sep; 83():88-98. PubMed ID: 28734146
[TBL] [Abstract][Full Text] [Related]
3. Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET/CT.
Michielsen K; Vergote I; Op de Beeck K; Amant F; Leunen K; Moerman P; Deroose C; Souverijns G; Dymarkowski S; De Keyzer F; Vandecaveye V
Eur Radiol; 2014 Apr; 24(4):889-901. PubMed ID: 24322510
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of whole-body diffusion-weighted MRI (WB-DWI/MRI) in diagnosis, staging and follow-up of gastric cancer, in comparison to CT: a pilot study.
De Vuysere S; Vandecaveye V; De Bruecker Y; Carton S; Vermeiren K; Tollens T; De Keyzer F; Dresen RC
BMC Med Imaging; 2021 Feb; 21(1):18. PubMed ID: 33546626
[TBL] [Abstract][Full Text] [Related]
5. Preoperative staging of ovarian cancer: comparison between ultrasound, CT and whole-body diffusion-weighted MRI (ISAAC study).
Fischerova D; Pinto P; Burgetova A; Masek M; Slama J; Kocian R; Frühauf F; Zikan M; Dusek L; Dundr P; Cibula D
Ultrasound Obstet Gynecol; 2022 Feb; 59(2):248-262. PubMed ID: 33871110
[TBL] [Abstract][Full Text] [Related]
6. Whole-body diffusion-weighted MRI for operability assessment in patients with colorectal cancer and peritoneal metastases.
Dresen RC; De Vuysere S; De Keyzer F; Van Cutsem E; Prenen H; Vanslembrouck R; De Hertogh G; Wolthuis A; D'Hoore A; Vandecaveye V
Cancer Imaging; 2019 Jan; 19(1):1. PubMed ID: 30616608
[TBL] [Abstract][Full Text] [Related]
7. Pre-operative evaluation of epithelial ovarian cancer patients: Role of whole body diffusion weighted imaging MR and CT scans in the selection of patients suitable for primary debulking surgery. A single-centre study.
Rizzo S; De Piano F; Buscarino V; Pagan E; Bagnardi V; Zanagnolo V; Colombo N; Maggioni A; Del Grande M; Del Grande F; Bellomi M; Aletti G
Eur J Radiol; 2020 Feb; 123():108786. PubMed ID: 31862634
[TBL] [Abstract][Full Text] [Related]
8. Predicting resectable disease in relapsed epithelial ovarian cancer by using whole-body diffusion-weighted MRI.
Dumont S; Vandecaveye V; Dresen RC; Van Nieuwenhuysen E; Baert T; Amant F; Broeckhoven V; Van Gorp T
Int J Gynecol Cancer; 2023 Dec; 33(12):1890-1897. PubMed ID: 37597854
[TBL] [Abstract][Full Text] [Related]
9. Patient satisfaction with ultrasound, whole-body CT and whole-body diffusion-weighted MRI for pre-operative ovarian cancer staging: a multicenter prospective cross-sectional survey.
Pinto P; Valentin L; Borčinová M; Wiesnerová M; Filip F; Burgetova A; Masek M; Lambert L; Chiappa V; Franchi D; Testa AC; Moro F; Avesani G; Panico C; Alessi S; Pricolo P; Vigorito R; Calareso G; Kocian R; Slama J; Fagotti A; Urbinati AMV; Signorelli M; Bertolina F; Cibula D; Fischerova D
Int J Gynecol Cancer; 2024 Jun; 34(6):871-878. PubMed ID: 38531539
[TBL] [Abstract][Full Text] [Related]
10. Whole body MRI, including diffusion-weighted imaging in follow-up of patients with testicular cancer.
Mosavi F; Laurell A; Ahlström H
Acta Oncol; 2015 Nov; 54(10):1763-9. PubMed ID: 25975210
[TBL] [Abstract][Full Text] [Related]
11. Whole-body MRI with diffusion-weighted imaging: a valuable alternative to contrast-enhanced CT for initial staging of aggressive lymphoma.
Balbo-Mussetto A; Cirillo S; Bruna R; Gueli A; Saviolo C; Petracchini M; Fornari A; Lario CV; Gottardi D; De Crescenzo A; Tarella C
Clin Radiol; 2016 Mar; 71(3):271-9. PubMed ID: 26749081
[TBL] [Abstract][Full Text] [Related]
12. Feasibility of whole-body diffusion-weighted MRI for detection of primary tumour, nodal and distant metastases in women with cancer during pregnancy: a pilot study.
Han SN; Amant F; Michielsen K; De Keyzer F; Fieuws S; Van Calsteren K; Dresen RC; Gziri MM; Vandecaveye V
Eur Radiol; 2018 May; 28(5):1862-1874. PubMed ID: 29218610
[TBL] [Abstract][Full Text] [Related]
13. Accuracy of Whole-Body DWI for Metastases Screening in a Diverse Group of Malignancies: Comparison With Conventional Cross-Sectional Imaging and Nuclear Scintigraphy.
Paruthikunnan SM; Kadavigere R; Karegowda LH
AJR Am J Roentgenol; 2017 Sep; 209(3):477-490. PubMed ID: 28678578
[TBL] [Abstract][Full Text] [Related]
14. Whole-body diffusion-weighted magnetic resonance imaging (WB-DW-MRI) vs choline-positron emission tomography-computed tomography (choline-PET/CT) for selecting treatments in recurrent prostate cancer.
Conde-Moreno AJ; Herrando-Parreño G; Muelas-Soria R; Ferrer-Rebolleda J; Broseta-Torres R; Cozar-Santiago MP; García-Piñón F; Ferrer-Albiach C
Clin Transl Oncol; 2017 May; 19(5):553-561. PubMed ID: 27796820
[TBL] [Abstract][Full Text] [Related]
15. Whole-body diffusion-weighted imaging vs. FDG-PET for the detection of non-small-cell lung cancer. How do they measure up?
Chen W; Jian W; Li HT; Li C; Zhang YK; Xie B; Zhou DQ; Dai YM; Lin Y; Lu M; Huang XQ; Xu CX; Chen L
Magn Reson Imaging; 2010 Jun; 28(5):613-20. PubMed ID: 20418042
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3 T compared to FDG-PET-CT.
Schmidt GP; Baur-Melnyk A; Haug A; Heinemann V; Bauerfeind I; Reiser MF; Schoenberg SO
Eur J Radiol; 2008 Jan; 65(1):47-58. PubMed ID: 18082989
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of whole-body diffusion-weighted magnetic resonance imaging for detection of primary and metastatic malignancies: a meta-analysis.
Li B; Li Q; Nie W; Liu S
Eur J Radiol; 2014 Feb; 83(2):338-44. PubMed ID: 24355655
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic Performance of Whole-Body Diffusion-Weighted Imaging Compared to PET-CT Plus Brain MRI in Staging Clinically Resectable Lung Cancer.
Usuda K; Sagawa M; Maeda S; Motono N; Tanaka M; Machida Y; Matoba TM; Watanabe N; Tonami H; Ueda Y; Uramoto H
Asian Pac J Cancer Prev; 2016; 17(6):2775-80. PubMed ID: 27356689
[TBL] [Abstract][Full Text] [Related]
19. Diffusion-weighted magnetic resonance imaging in peritoneal carcinomatosis from suspected ovarian cancer: Diagnostic performance in correlation with surgical findings.
Garcia Prado J; González Hernando C; Varillas Delgado D; Saiz Martínez R; Bhosale P; Blazquez Sanchez J; Chiva L
Eur J Radiol; 2019 Dec; 121():108696. PubMed ID: 31683251
[TBL] [Abstract][Full Text] [Related]
20. Multiparametric Whole-body MRI with Diffusion-weighted Imaging and ADC Mapping for the Identification of Visceral and Osseous Metastases From Solid Tumors.
Jacobs MA; Macura KJ; Zaheer A; Antonarakis ES; Stearns V; Wolff AC; Feiweier T; Kamel IR; Wahl RL; Pan L
Acad Radiol; 2018 Nov; 25(11):1405-1414. PubMed ID: 29627288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
